Placement of Subcutaneous Central Venous Ports in Breast Cancer Patients: Does Side Matter?

Isom, Chelsea A.; Bream, Peter R.; Gallagher, Kathleen C.; Walia, Sonal; Ahmed, Ryan; Kauffmann, Rondi M.

doi:10.1016/j.jss.2019.06.028

Cited by 8 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, in recent years, more and more studies demonstrated that there was no difference in port complications or lymphedema rates between patients who had ports placed on the ipsilateral side compared with the contralateral side for breast cancer treatment. 22,27 There are still some problems to be addressed further. First, in our study, there are about half of the patients with ipsilateral subclavian PC received radiotherapy.…”

Section: Discussionmentioning

confidence: 99%

“…Some traditional surgeons take the opinion that the veins of ipsilateral sick side should avoid blood drainage and central venous catheter insertion to aggravate lymphedema. However, in recent years, more and more studies demonstrated that there was no difference in port complications or lymphedema rates between patients who had ports placed on the ipsilateral side compared with the contralateral side for breast cancer treatment 22,27 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practice

Liu

et al. 2020

Cancer Medicine

View full text Add to dashboard Cite

Background Port catheter (PC) is a classical route of administering chemotherapy for breast cancer patients. We established a standard operating procedure (SOP) of intraoperative ipsilateral subclavian PC implantation in selected resectable breast cancer patients. Methods We conducted a prospective clinical study to assess its safety and complications. A total of seventy six resectable breast cancer patients were included for intraoperative ipsilateral subclavian PC implantation. Thirty patients receiving conventional percutaneous contralateral PC implantation under local anesthesia at the same period were recruited as control group. The time consuming of implantation, and PC‐related complications were recorded. Visual analog scale questionnaires were used to assess patients’ satisfaction. Results Compared with conventional contralateral PC implantation under local anesthesia, SOP for intraoperative ipsilateral subclavian PC implantation significantly shortens the time consuming (11.6 vs. 28.6 min, p < 0.001). With a median retention time of 6.3 months, the overall incidence rate of PC‐related complications is 21%, of which the most common complications are infections and venous thromboembolism (7.9% for each). Most patients (86.8%) with intraoperative ipsilateral subclavian PC implantation have completed the whole chemotherapy successfully. Due to the general anesthesia and shorter time consuming, intraoperative implantation gains significantly more patients' satisfaction. Conclusions In the present study, we develop a SOP for intraoperative ipsilateral subclavian PC implantation in resectable breast cancer patients, which is noval, convenient, and safe. In selected breast cancer patients with indications for adjuvant chemotherapy, this practice could significantly shorten the time consuming of PC implantation and improve the degree of patients' satisfaction.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%